Value of P53 protein expression and its relationship with short-term prognosis in colorectal cancer

Annals of Saudi Medicine

Volumn 22, Issue 5-6, 2002, Pages 377-380

  Erhan, Yamaç ^a   Korkut, Mustafa Ali ^c   Kara, Eray ^a   Aydede, Hasan ^a   Sakarya, Aslan ^a   Ilkgül, Özer ^b  

^a EGE UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0036765601     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2002.377     Document Type: Article

References (17)

1. Harris AL. Mutant p53: the commonest genetic abnormality in human cancer (editorial) J Pathol 1990;162:5-6.
2. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Clearly K, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-8.
3. Baker SK, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science 1989;244:217-21.
4. Vogelstein B, Fearon ER, Hamilton MD, et al. Genetic alterations during colorectal tumour development. N Engl J Med 1988;319:525.
5. Lane DP: p53: guardian of the genome. Nature 1992;358:15.
6. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Wilson JKV, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
7. Chung M, Mitmaker B, Gordon PH, et al. Expression of the c-fos proto-oncogenes, the p53 anti-oncogene and statin in colorectal carcinoma and adjacent mucosa. Surg Forum 1991;42:427.
8. Offerhaus GJA, de Feyter EP, Cornelisse CJ, Termstte KWF, Floyed J, Kern SE, et al. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 1992; 102:1612-9.
9. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172:5-12.
10. Zeng ZS, Sarkias AS, Zhang ZF, et al. p53 nuclear over-expression: an independent predictor of survival in lymph node positive colorectal cancer patients. J Clin Oncol 1994;12:2043-50.
11. Belluco C, Guillem J, Kemeny N, et al. p53 nuclear protein over-expression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases. J Clin Oncol 1996;14:2696.
12. Bouzourene H, Gervaz P, Cerottini JP, Benhattar J, Chaubert P, Saraga E, et al. P53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer. Eur J Cancer 2000;36:1008-15.
13. Yamaguchi A, Kurosaka Y, Fushida S, Kanno M, Yonemura Y, Miwa K, Miyazaki I. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992;70:2778-84.
14. Giatromanolaki A, Stathopoulos GP, Tsiobanou E, Papadimitriou C, Geogoulias V, Gatter KC, Harris AL, Koukourakis MI. Combined role of tumour angiogenesis: Bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 1999;86: 1421-30.
15. Kahlenberg MS, Stoler DL, Rodriguez-Bigas MA, Weber TK, Driscoll DL, Anderson GR, Petrelli NJ. P53 tumour suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. Cancer 2000;88:1814-9.
16. Grewal H, Guillem JG, Klimstra DS, Cohen AM. P53 nuclear over expression may not be an independent prognostic marker in early colorectal cancer. Dis Colon Rectum 1995;38:1176-81.
17. Gallego MG, Acenero, MJ, Ortega S, Delgado AA, Cantero JL. Prognostic influence of p53 nuclear overexpression in colorectal carcinoma. Dis Colon Rectum 2000;43:971-5.